Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/elsevier/comparative-effects-of-a-contraceptive-vaginal-ring-delivering-a-PQTsppfy8a
References (17)
-
M. Alhenc‐Gelas, G. Plu-Bureau, Sophie Guillonneau, J. Kirzin, M. Aiach, N. Ochat, P. Scarabin (2004)
Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptivesJournal of Thrombosis and Haemostasis, 2
-
C. Kluft, P. Meijer (1996)
Update 1996: Blood collection and handling procedures for assessment of plasminogen activators and inhibitors (Leiden Fibrinolysis Workshop)Fibrinolysis and Proteolysis, 10
-
L. Heinemann, J. Dinger (2004)
Safety of a New Oral Contraceptive Containing DrospirenoneDrug Safety, 27
-
Croxatto (1992)
Transdermal contraceptive systems: innovative technology for the twenty-first century -
H. Out, J. Jespersen, I. Pabinger, K. Macrae, P. Crosignani, S. Skouby, U. Winkler, L. Norris, U. Gaspard, David, A. Enk, A. Ende, D. Mishell, D. Voncken, C. Klipping, J. Sidelmann (2003)
The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study.Contraception, 67 3
-
R. Sitruk-Ware, M. Small, Narender Kumar, Y. Tsong, K. Sundaram, T. Jackanicz (2003)
Nestorone®: clinical applications for contraception and HRTSteroids, 68
-
C. Mashchak, R. Lobo, R. Dozono-Takano, P. Eggena, R. Nakamura, P. Brenner, D. Mishell (1982)
Comparison of pharmacodynamic properties of various estrogen formulations.American journal of obstetrics and gynecology, 144 5
-
Lothar Heinemann, C. Kluft, Michael Spannagl, M. Maat (2002)
The association between extrinsic activated protein C resistance and venous thromboembolism in women.Contraception, 66 5
-
V. Odlind, I. Milsom, I. Persson, A. Victor (2002)
Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?Acta Obstetricia et Gynecologica Scandinavica, 81
-
F. Álvarez-Sánchez, V. Brache, T. Jackanicz, A. Faúndes (1992)
Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control and lipid profiles.Contraception, 46 4
-
I. Sivin, D. Mishell, F. Alvarez, V. Brache, K. Elomaa, P. Lähteenmäki, R. Massai, P. Miranda, H. Croxatto, C. Dean, M. Small, H. Nash, T. Jackanicz (2005)
Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial.Contraception, 71 2
-
U. Winkler (1998)
Blood coagulation and oral contraceptives. A critical review.Contraception, 57 3
-
I. Sivin, H. Croxatto, L. Bahamondes, V. Brache, F. Alvarez, R. Massai, Janet Schechter, S. Ranta, Narender Kumar, E. Wu, A. Tejeda, V. Reyes, E. Travers, Arthur Allen, A. Moo-Young (2004)
Two-year performance of a Nestorone-releasing contraceptive implant: a three-center study of 300 women.Contraception, 69 2
-
S. Middeldorp, J. Meijers, A. Ende, Adam Enk, B. Bouma, G. Tans, J. Rosing, M. Prins, H. Büller (2000)
Effects on Coagulation of Levonorgestrel- and Desogestrel-containing Low Dose Oral Contraceptives: a Cross-over StudyThrombosis and Haemostasis, 84
-
Narender Kumar, S. Koide, Y. Tsong, K. Sundaram (2000)
Nestorone®: a progestin with a unique pharmacological profileSteroids, 65
-
E. Johansson, R. Sitruk-Ware (2004)
New delivery systems in contraception: vaginal rings.American journal of obstetrics and gynecology, 190 4 Suppl
-
N. Alexander, E. Baker, Marc Kaptein, U. Karck, L. Miller, E. Zampaglione (2004)
Why consider vaginal drug administration?Fertility and sterility, 82 1
- Publisher
- Wolters Kluwer Health
- Copyright
- Copyright © 2006 Mosby, Inc.
- ISSN
- 0002-9378
- DOI
- 10.1016/j.ajog.2005.12.007
- pmid
- 16545330
- Publisher site
- See Article on Publisher Site
Abstract
Objective This study aimed to compare the effects on hemostasis variables of a contraceptive vaginal ring with those of an oral contraceptive.
Journal
American Journal of Obstetrics and Gynecology – Wolters Kluwer Health
Published: Jul 1, 2006